Submitted by Anonymous (not verified) on 22 December 2025 - 14:10
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 11, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 11, Status: Authorised